Vicki DiFrancesco Joins XIFIN as Chief Strategy Officer

| April 26, 2017

Former Pathology, Inc. CEO Vicki DiFrancesco Joins XIFIN as Chief Strategy Officer

SAN DIEGO– XIFIN Inc., the healthcare information technology company revolutionizing the business of healthcare diagnostics, has appointed Vicki DiFrancesco as its Chief Strategy Officer.

DiFrancesco, one of the most influential leaders in the laboratory industry, will be responsible for building and executing XIFIN’s corporate business development strategies including acquisitions, joint ventures and strategic partnerships that advance company growth.

“We are honored that a lab executive with Vicki’s remarkable business achievements has joined our team, and cannot think of a more ideal person to hold the position of Chief Strategy Officer,” stated Lâle White, CEO of XIFIN. “Vicki has successfully led a number of organizational transformations for several of our nation’s leading laboratory businesses. She is a true visionary, and adding her talents to our executive team underscores XIFIN’s commitment to scaling our business and executing on our growth strategy as part of our mission to improve the economics of healthcare.”

DiFrancesco is an accomplished diagnostics executive with more than 25 years in executive leadership positions, most recently serving as president and CEO of Pathology Inc., the west coast’s premier women’s health laboratory that was acquired by LabCorp in March 2016. Previously, DiFrancesco served as senior vice president, sales and marketing for Specialty Laboratories Inc.; executive vice president of sales and marketing for Spectrum Laboratory Network; and vice president of hospital sales and marketing at Quest Diagnostics, Inc. She has also held executive level positions with American Medical Laboratories and Laboratory Corporation of America.

“I’m very excited to work with Lâle and her team at XIFIN; I believe XIFIN is one of the few diagnostic companies today in a position to integrate clinical and financial data in a meaningful way to improve healthcare economics,” stated DiFrancesco. “In my new role as CSO, I look forward to increasing XIFIN’s leadership position, supporting its rapidly growing installed base of customers, and helping the company dominate the diagnostics space with innovative solutions and services.”

DiFrancesco currently serves on the Board of Directors of PWNHealth, LLC. She holds a BS degree in biological sciences from California State University, Sacramento.

About XIFIN, Inc.

XIFIN is a healthcare information technology company that leverages diagnostic information to improve the quality and economics of healthcare. The company’s health economics optimization platform is a connected health solution that facilitates connectivity and workflow automation for accessing and sharing clinical and financial diagnostic data, linking healthcare stakeholders in the delivery and reimbursement of care. To learn more, visit or follow XIFIN on Twitter and LinkedIn.

Tags: , , , , , ,

Category: Anatomic Pathology, Business, Clinical Laboratories, Clinical Pathology, Cloud Computing, Data Management, Device Manufacturers, Digital Pathology News, Electronic Medical Records, Informatics, Laboratory Informatics, Laboratory Information Systems, Laboratory Management & Operations, Pathology News, TeleHealth

Comments are closed.